Friday broker round-up UPDATE
19th Apr 2013 08:47
African Barrick Gold: JP Morgan cuts target price from 290p to 200p, while leaving its underweight rating rating unchanged. Fox Davies reduces target price from 353p to 315p and maintains a hold rating. Westhouse Securities lowers target price from 195p to 180p retaining a neutral rating. Belvoir L
Read moreFTSE 100 movers: GSK rises on COPD treatment approval
18th Apr 2013 14:59
Shares in pharmaceuticals giant GlaxoSmithKline gained after the the US FDA approved Breo Ellipta, the company's treatment for chronic obstructive pulmonary disease (COPD). "This positive recommendation is a crucial first step towards making Breo Ellipta available for appropriate COPD patients acros
Read moreLondon midday: Markets snap four-day losing streak
18th Apr 2013 11:17
Developments in the Eurozone were supporting stocks on Thursday morning as markets rebounded to snap a four-day losing streak. However, the focus is likely to turn to the US later on as first-quarter earnings season continues to dictate sentiment. Wall Street benchmarks slumped last night after som
Read moreGlaxoSmithKline shares rise on FDA approval of Breo Ellipta
18th Apr 2013 08:50
GlaxoSmithKline's shares rose Thursday after the healthcare company announced US approval of Breo Ellipta, a treatment for chronic obstructive pulmonary disease (COPD). Breo Ellipta, once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with COPD,
Read moreTuesday broker round-up UPDATE
16th Apr 2013 07:33
Aberdeen Asset Management: Citigroup ups target price from 430p to 455p retaining a neutral rating. Associated British Foods: Credit Suisse moves target price from 1650p to 1850p, but downgrades from outperform to neutral. AZ Electronic Materials: Espirito Santo initiates with a target price of 40
Read moreLondon close: Stocks, commodities drop after Chinese slowdown
15th Apr 2013 17:04
Worries surrounding the global economy hammered equities worldwide on Monday after disappointing growth figures from China sparked a sell-off across commodity markets and the mining sector. A better-than-expected first-quarter earnings report from US bellwether Citigroup did little to lift sentimen
Read moreFTSE 100 movers: Fresnillo leads miners lower
15th Apr 2013 15:26
Metals producers were under the weather throughout the day on Monday after the disappointing economic data. Fresnillo and Polymetal were the worst hit, both down over 10 per cent by late afternoon, while Randgold and Evraz weren't far behind. Polymetal was being dragged lower by a downgrade from C
Read moreMonday broker round-up UPDATE
15th Apr 2013 09:50
African Barrick Gold: Citigroup cuts target price from 267p to 175p and keeps its sell recommendation. African Minerals: Goldman Sachs lowers target price from 420p to 410p keeping a buy recommendation. Citigroup moves target price from 440p to 430p and retains a buy recommendation. Anglo American
Read moreFriday broker round-up UPDATE
12th Apr 2013 07:25
Aggreko: Panmure Gordon raises target price fro, 1727p to 2106p and upgrades from hold to buy. Alternative Networks: Westhouse Securities moves target price from 280p to 295p and reiterates a neutral rating. Investec raises target price from 330p to 350p maintaining a buy recommendation. Finncap in
Read moreLondon close: Resource-heavy FTSE 100 lifted by slowing Chinese inflation
9th Apr 2013 16:37
Slowing inflation in China and a strong start to the US earnings season by Alcoa boosted the UK's resource-heavy FTSE 100 stock index on Tuesday, with miners leading the surge. Meanwhile, a raft of upbeat economic data from closer to the home lifted sentiment in the UK today, including better-than-
Read moreBroker tips: Centamin, FirstGroup, BP...
9th Apr 2013 11:00
Canaccord Genuity has kept its 'sell' rating and 38p target price for Egyptian gold miner Centamin despite the strong first-quarter production figures announced on Tuesday morning, saying that legal issues still remain. The broker said: "Although we would expect shares to be stronger today we think
Read moreBroker snap: Tradenext highlights buying opportunities on recent sterling weakness
9th Apr 2013 10:48
Tradenext has highlighted a list of attractive opportunities on the London stock market given the recent weakness of the sterling pound. "A fall in the value of sterling will further support FTSE100 stocks and earnings, and make it easier for UK companies to sell their products overseas," said Ronn
Read moreMonday broker round-up UPDATE
11th Mar 2013 07:23
Admiral Group: Berenberg ups target price from 1000p to 1060p, but still recommends selling. Amlin: Westhouse Securities raises target price from 440p to 455p, but downgrades from add to neutral. Anite Group: Invetsec downgrades from buy to hold with a target price of 157p. Aviva: Citigroup reduc
Read moreGlaxoSmithKiline seeks authorisation for type-2 diabetes treatment
7th Mar 2013 13:05
FTSE-100 listed pharmaceutical giant GlaxoSmithKline (GSK) has submitted a marketing authorisation application (MAA) for its albiglutide treatment to the European Medicines Agency (EMA). The product is an investigational once-weekly treatment for adult patients with type-2 diabetes which is not ye
Read moreLondon open: Fed comments provide support ahead of BoE, ECB
7th Mar 2013 08:43
The FTSE 100 held on to recent gains on Thursday morning ahead of central-bank policy decisions in the UK and Europe, as comments from the Federal Reserve provided some support. According to the Fed's Beige Book released last night, the US economy expanded at a "modest to moderate pace" at the star
Read more